NDA 065380 describes SUPRAX, which is a drug marketed by
Lupin Ltd,
Lederle, and
Lupin Pharms, and is included in eight NDAs. It is available from
two suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the
SUPRAX profile page.
The generic ingredient in SUPRAX is
cefixime. There are fourteen
drug master file entries for this compound. Eight
suppliers are listed for this compound. Additional details are available on the
cefixime profile page.